StockNews.AISignal intelligence
Company intelligence

MTSR

MTSR

Price—Latest market price
Market cap—Equity value
P / E—Trailing ratio
Volume—Latest session
Market data

MTSR price chart

TradingView
Related signals
1 min delayed

Browse public MTSR signals with their source context and measured market impact. Open any signal for its permanent analysis page.

MTSRNov 10, 2025+0.21% since signal

Pfizer Wins Battle for Weight-Loss Drugmaker Metsera. Novo Nordisk Is the Real Winner.

Metsera's stock fell 15% post-Pfizer's $10 billion acquisition agreement. Pfizer offers $65.60 per share, plus potential $20.65 contingent payments. Novo Nordisk declined to raise bid, focusing on financial discipline. Market reaction indicates investor relief as Novo opts not to compete further. Pfizer aims to finalize the deal post Metsera's stockholder meeting.

View signal analysis
Research

Company intelligence